Correlation study between serum asprosin levels and tic disorders in children

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2600129048

Enrollment

Unknown

Registered

2026-07-29

Start date

2026-07-30

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tic disorders in children

Interventions

TD group:None

control group:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. TD Group Inclusion Criteria: (1) Meets the diagnostic criteria for Tic Disorders (DSM-5); (2) The patient and their family are informed and voluntarily participate in the study. 2. Inclusion Criteria for the Control Group Children of matching age and gender who underwent health check-ups at our hospital

Exclusion criteria

Exclusion criteria: 1. Electroencephalogram (EEG) and cranial MRI show specific changes, with abnormal main indicators in tests for liver and kidney function, etc. 2. Tics are clearly caused by medications (such as stimulants, antipsychotic drugs) or other systemic diseases (such as Huntington's chorea, Sydenham's chorea, post-viral encephalitis, epilepsy and clonic seizures, choreoathetosis, Wilson's disease, and other extrapyramidal disorders); 3. Individuals with other somatic functional disorders and organic brain diseases; 4. Those currently participating in clinical trials of other drugs.

Design outcomes

Primary

Measure	Time frame
Asprosin;	—

Countries

China

Contacts

Public ContactWu Shirun

First Hospital of Shanxi Medical University

wsr0351@163.com+86 351 486 7228

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026